|
Name: 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)
Type: Psychedelic phenethylamine
AKA: 2C-D
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
2C-D, a psychedelic phenethylamine, was first synthesized in the 1970s by Alexander Shulgin. It is known for its hallucinogenic effects and has been used in both recreational and research settings. 2C-D's development reflects a broader interest in psychoactive compounds. Its legal status has varied, with ongoing debates about its safety and therapeutic potential.
|
|
V. Legal Information
2C-D, a psychedelic phenethylamine, is classified as a Schedule I controlled substance in the US, making it illegal. Many countries have similarly banned it due to its potent psychoactive effects and health risks. The UNODC monitors new psychoactive substances, emphasizing the need for international regulation to prevent misuse. Trends show increasing control measures to address the growing issue of synthetic drug use.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
2C-D is a psychedelic phenethylamine that acts as an upper, causing altered perception and euphoria. Short-term use can lead to intense sensory experiences, while long-term effects are not well-documented. Overdose risks include severe psychological distress. Safe use involves cautious dosing. Recent research explores its psychoactive effects and potential therapeutic uses.  |
|
VII. Psychological Effects
N/A
 |
|
VIII. Culture
2C-D is a psychedelic phenethylamine causing altered perception and hallucinations, classifying it as neither an upper nor a downer. Short-term use induces euphoria, visual distortions, and altered consciousness, while long-term use is not well-documented. Overdose can result in severe agitation, confusion, and cardiovascular issues. Safe dosages are not well-established, with lower doses advised. Recent research focuses on its psychotropic effects and potential therapeutic uses. Physical signs include dilated pupils, increased heart rate, and elevated blood pressure.
 |